Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 12 March 1971:
Vol. 171. no. 3975, pp. 1032 - 1036
DOI: 10.1126/science.171.3975.1032
Prev | Table of Contents | Next

Articles

Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

Larry Stein 1 and C. David Wise 1

1 Wyeth Laboratories, Inc., Philadelphia, Pennsylvania 19101

Single or repeated intraventricular injections of 6-hydroxydopamine caused marked and long-lasting deficits in brain self-stimulation and other rewarded behaviors in the rat. The behavioral deficits, as well as the depletion of brain norepinephrine induced by 6-hydroxydopamine, were prevented by prior treatment with chlorpromazine. Episodic or continuous formation of endogenous 6-hydroxydopamine in man as a result of a genetically determined enzymatic error could selectively damage the binding capacity and, eventually, the structural integrity of the noradrenergic reward mechanism. Such damage might cause the fundamental symptoms and long-term downhill course of schizophrenia.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cognitive Rehabilitation for Schizophrenia and the Putative Role of Motivation and Expectancies.
D. I. Velligan, R. S. Kern, and J. M. Gold (2006)
Schizophr Bull 32, 474-485
   Abstract »    Full Text »    PDF »
Constraints on Concepts of Pathogenesis: Language and the Speciation Process as the Key to the Etiology of Schizophrenia.
T. J. Crow (1995)
Arch Gen Psychiatry 52, 1011-1014
   Abstract »    PDF »
Maintenance Imipramine Therapy for Secondary Depression in Schizophrenia: A Controlled Trial.
S. G. Siris, P. C. Bermanzohn, S. E. Mason, and M. A. Shuwall (1994)
Arch Gen Psychiatry 51, 109-115
   Abstract »    PDF »
Putting the 'A' in atypical: does {alpha}2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?.
D. J. Nutt (1994)
J Psychopharmacol 8, 193-195
   PDF »
L-dopa helps positive but not negative features of neuroleptic-insensitive chronic schizophrenia.
D.G.C. Owens, P.E. Harrison-Read, and E. C. Johnstone (1994)
J Psychopharmacol 8, 204-212
   Abstract »    PDF »
Norepinephrine in Acute Exacerbations of Chronic Schizophrenia: Negative Symptoms Revisited.
D. P. van Kammen, J. Peters, J. Yao, W. B. van Kammen, T. Neylan, D. Shaw, and M. Linnoila (1990)
Arch Gen Psychiatry 47, 161-168
   Abstract »    PDF »
Cholinergic Hyperactivity and Negative Schizophrenic Symptoms: A Model of Cholinergic/Dopaminergic Interactions in Schizophrenia.
R. Tandon and J. F. Greden (1989)
Arch Gen Psychiatry 46, 745-753
   Abstract »    PDF »
Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy.
D. van Kammen, L. Mann, D. Sternberg, M Scheinin, P. Ninan, Marder SR, W. van Kammen, R. Rieder, and M Linnoila (1983)
Science 220, 974-977
   Abstract »    PDF »
Assessing Anhedonia in Psychiatric Patients: The Pleasure Scale.
J. Fawcett, D. C. Clark, W. A. Scheftner, and R. D. Gibbons (1983)
Arch Gen Psychiatry 40, 79-84
   Abstract »    PDF »
Plasma Norepinephrine and Dopamine-{beta}-Hydroxylase Activity in Schizophrenia.
S. Castellani, M. G. Ziegler, D. P. van Kammen, P. E. Alexander, S. G. Siris, and C. R. Lake (1982)
Arch Gen Psychiatry 39, 1145-1149
   Abstract »    PDF »
6-Hydroxydopamine and anticholinergic drugs.
S. Mason and H. Fibiger (1978)
Science 202, 1215-1217
   PDF »
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food.
R. Wise, J Spindler, H deWit, and G. Gerberg (1978)
Science 201, 262-264
   Abstract »    PDF »
Probenecid-Induced Norepinephrine Elevations in Plasma and CSF.
C. R. Lake, J. H. Wood, M. G. Ziegler, M. H. Ebert, and I. J. Kopin (1978)
Arch Gen Psychiatry 35, 237-240
   Abstract »    PDF »
Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia.
R. M. Post, E. Fink, W. T. Carpenter Jr, and F. K. Goodwin (1975)
Arch Gen Psychiatry 32, 1063-1069
   Abstract »    PDF »
Overview of Recent Research in Depression: Integration of Ten Conceptual Models Into a Comprehensive Clinical Frame.
H. S. Akiskal and W. T. McKinney Jr. (1975)
Arch Gen Psychiatry 32, 285-305
   Abstract »    PDF »
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.
R. Yokel and R. Wise (1975)
Science 187, 547-549
   Abstract »    PDF »
Brain Peroxidase and Catalase in Parkinson Disease.
L. M. Ambani, M. H. Van Woert, and S. Murphy (1975)
Arch Neurol 32, 114-118
   Abstract »    PDF »
Inhibition of Dopamine-B-Hydroxylase in Manic Patients: A Clinical Trial With Fusaric Acid.
R. L. Sack and F. K. Goodwin (1974)
Arch Gen Psychiatry 31, 649-654
   Abstract »    PDF »
Central Dopamine Turnover in Schizophrenic Syndromes.
M. B. Bowers Jr. (1974)
Arch Gen Psychiatry 31, 50-54
   Abstract »    PDF »
Dopamine Nerve Terminals in the Rat Limbic Cortex: Aspects of the Dopamine Hypothesis of Schizophrenia.
T. Hokfelt, A. Ljungdahl, K. Fuxe, and O. Johansson (1974)
Science 184, 177-179
   Abstract »    PDF »
Recovery of Feeding and Drinking by Rats after Intraventricular 6-Hydroxydopamine or Lateral Hypothalamic Lesions.
M. J. Zigmond and E. M. Stricker (1973)
Science 182, 717-720
   Abstract »    PDF »
Depressive Disorders: Toward a Unified Hypothesis: Clinical, experimental, genetic, biochemical, and neurophysiological data are integrated.
H. S. Akiskal and W. T. McKinney Jr. (1973)
Science 182, 20-29
   Abstract »    PDF »
Behavior of Free-Ranging Macaques after Intraventricular 6-Hydroxydopamine.
D. E. Redmond Jr., R. L. Hinrichs, J. W. Maas, and A. Kling (1973)
Science 181, 1256-1258
   Abstract »    PDF »
Dopamine.-beta-Hydroxylase Deficits in the Brains of Schizophrenic Patients.
C. D. Wise and L. Stein (1973)
Science 181, 344-347
   Abstract »    PDF »
Dopaminergic and Noradrenergic Substrates of Positive Reinforcement: Differential Effects of d- and l-Amphetamine.
A. G. Phillips and H. C. Fibiger (1973)
Science 179, 575-577
   Abstract »    PDF »
Diffusion and Chemical Transformation: An interdisciplinary excursion.
P. B. Weisz (1973)
Science 179, 433-440
   PDF »
6-Hydroxydopamine, Noradrenergic Reward, and Schizophrenia.
S. M. Antelman, A. S. Lippa, A. E. Fisher, M. B. Bowers Jr., M. H. Van Woert, J. S. Strauss, W. T. Carpenter Jr., L. Stein, and C. D. Wise (1972)
Science 175, 919-923
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)